Cortica Inc. Announces Equity Investment Led by Questa Capital
November 13, 2018
Investment to Support Continued Innovation and National Expansion of Integrated Care Model for Autism
SAN DIEGO, CA—Cortica Inc. (“Cortica”), a leading provider of advanced neurological therapies for children with autism and other neurodevelopmental conditions, announced today an equity investment led by Questa Capital Management with participation by Aperture Venture Partners. The investment will be used to accelerate the rollout of the company’s comprehensive care model for autism nationally and support ongoing technological innovation around clinical care delivery and the patient experience. Cortica is led by its co-founders, CEO Neil Hattangadi, M.D. and Chief Medical Officer Suzanne Goh, M.D. Dr. Hattangadi is an experienced healthcare operating executive who most recently served as President/COO of Spirox (acquired by Entellus Medical), and previously founded and led the Peripheral Vascular business at Volcano Corporation and Royal Philips. Dr. Goh is a pediatric neurologist, author, and neuroscience researcher who previously served as co-director of Columbia University’s autism treatment program in New York City. With autism diagnoses increasing in recent years, the average demand for treatment is 18x greater than the available supply of caregivers, based on a 2017 study published by the Stanford University School of Medicine1. Cortica has developed a more comprehensive treatment model addressing multiple domains of autism care based on years of clinical research and practice by Dr. Goh and other Cortica clinical leaders. Cortica’s multi-dimensional care model incorporates the best evidence-based therapies in neurophysiology, biochemistry, sensorimotor integration, communication, cognition and behavior to create a comprehensive roadmap for a child with autism and their family. “Since establishing Cortica in 2014, we have attracted families from around the world to our clinics in Southern California who are seeking an expert, integrated team to provide comprehensive care for their child with neurodevelopmental conditions. We are excited to partner with Questa to support our continued innovation and to expand our footprint to meet more of the local and national need,” commented Dr. Hattangadi. “We are thrilled to have partners with such a deep understanding of autism and a great appreciation for our patient-centric mission.” “Neil, Suzanne and their team have done a remarkable job building Cortica into a leading autism treatment provider,” said Ryan Drant, Founder and Managing Director of Questa Capital. “With a unique integrated care model staffed by world renowned clinicians serving the most challenging patients, Cortica is providing a critical service to families, and we are honored to serve as their partner in building a great company to address this underserved need.” “After studying the autism market for years, we have been impressed with Cortica’s commitment to clinical excellence and differentiated approach to achieving transformative patient outcomes,” remarked Brad Sloan, Managing Director of Questa Capital. “Given our deep healthcare experience, we are excited to assist the Cortica team to execute on its vision to revolutionize autism care by providing an innovative and comprehensive set of in-clinic, in-home and tele-health solutions to children and their families.” 1 JMIR Public Health Surveill 2017 (May 04); 3(2):e27
About Cortica Inc.
Cortica Inc. is a leading provider of advanced neurological therapies for children with autism and other neurodevelopmental conditions. The company offers a comprehensive set of services through its integrated care model that incorporates therapies across neurophysiology, biochemistry, sensorimotor integration, communication, cognition and behavior. Cortica delivers its services in-clinic, in-home, and via telehealth to empower families to achieve long-lasting, transformative results. Headquartered in San Diego, the company operates four clinics in California serving global patients seeking a more advanced treatment for autism. For more information, please visit www.corticacare.com.
About Questa Capital
Questa Capital is a venture growth equity firm focusing on investments in growth-stage healthcare companies. Questa seeks out disruptive, technology-enabled business models that help improve patient lives and provide better quality and more efficient care. The firm partners with superior management teams to help build innovative market leaders. Questa is led by industry veterans in healthcare investment and operations who have invested in and advised more than 45 growth-stage companies over the past twenty years. More information is available at www.questacapital.com.
Media: Michele Rest Head of Corporate Communications Cortica Inc. 858-304-6440 [email protected]